Penn Startups Raising Capital – Spring 2022
PCI supports and facilitates startup formation and growth through our startup creation programs and our licensing partnerships. This list of Penn affiliated startups are actively fundraising.
Medical device startup Neuralert has big 2022 plans
The device's algorithm maps out asymmetric arm movements or weakness, a tell-tale sign of a stroke, CEO Eric Corkhill said. Here's why he's so excited about its potential.
Two Penn spinouts on the Technical.ly Philly RealLIST standout tech companies
Of the 20 companies on the Technical.ly Philly RealLIST, two are Penn spinout companies: Lumify and Neuralert.
ExynAI has been shortlisted as a finalist for a SXSW Innovation Award
For the 2022 category of Robotics and Hardware. The Exyn team will be going to Austin for the awards.
Cogwear is featured on the cover of the Journal of Precision Medicine
The Journal of Precision Medicine highlighted Penn spinout Cogwear’s novel technology for behavioral health applications.
Moderna forms oncology collaboration with Carisma Therapeutics
Moderna will collaborate with Penn spinout Carisma Therapeutics to discover, develop and commercialize in-vivo engineered chimeric antigen receptor monocyte therapeutics for the treatment of cancer.
iECURE partners to develop next-generation liver-targeted lipid nanoparticles with Penn
iECURE announced that it has entered into an exclusive agreement with Penn to develop next-generation lipid nanoparticles (LNP) for liver gene editing applications.
Scout Bio licenses new Penn technology to help develop gene therapies for pets
Scout Bio, a Philadelphia company developing gene therapies for animal health, has licensed a new kind of technology from the Penn’s gene therapy program.
Passage Bio further expands Gene Therapy research partnership with Penn
Passage Bio has exercised two additional options for potential new drug candidates under its research collaboration with Penn's gene therapy program.
Cogwear and Rezon to make brain enhancing wearable for athletes
Strategic partnership combines the start-ups’ revolutionary technologies for brain injury reduction and cognitive performance